Korean J Obstet Gynecol.  2012 Jul;55(7):447-453. 10.5468/KJOG.2012.55.7.447.

What is the proper work-up of the patient with clinical early stage uterine adenocarcinoma?

• Patsner B
• Anderson M

• KMID: 1992553
• DOI: http://doi.org/10.5468/KJOG.2012.55.7.447

Abstract

OBJECTIVE
To discuss the proper preoperative workup of patients with uterine adenocarcinoma who present with disease clinically confined to the uterine corpus.
METHODS
Review of recommendations suggested in major textbooks in gynecologic oncology over the past thirty five years as well as select recent publications in the gynecologic oncology literature in Asia as well as the United States and Europe.
RESULTS
The suggested preoperative testing for the patient population under consideration has evolved over the years depending on whether the patient is at low risk or high risk for occult metastatic disease.
CONCLUSION
Standard preoperative testing is always indicated but preoperative CA-125 and advanced radiological imaging are never routinely indicated for "low risk" patients. Either test may be indicated in select high-risk patients in the setting of clinical investigation though it is unclear which test, if either, provides enough meaningful clinical information which will either alter surgical management or which may be justified in light of the predicted high percentage of patients who will have normal preoperative test results.

Keyword

Uterine adenocarcinoma; Preoperative evaluation; CA-125

MeSH Terms

Adenocarcinoma
Asia
Humans
Light
United States

Reference

1. Division of Gynecologic Oncology (Department of Obstetrics and Gynecology, Severance Hospital, Yonsei College of Medicine, Seoul, Korea). Uterine Cancer Treatment Protocol. 2011. 10.

2. DiSaia PJ, Morrow CP, Townsend DE. Synopsis of gynecologic oncology. 1975. New York: Wiley.

3. Creasman WT. DiSaia PJ, Creasman WT, editors. Adenocarcinoma of the uterus. Clinical gynecologic oncology. 1984. 5nd ed. St. Louis: Mosby;147–184.

4. Berek JS, Hacker N. Practical gynecologic oncology. 2005. 4th ed. Philadelphia: Lippincott Williams & Wilkins.

5. Zerbe MJ, Bristow R, Grumbine FC, Montz FJ. Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol. 2000. 78:67–70.

6. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology. 1991. 179:829–832.

7. Jhang H, Chuang L, Visintainer P, Ramaswamy G. CA 125 levels in the preoperative assessment of advanced-stage uterine cancer. Am J Obstet Gynecol. 2003. 188:1195–1197.

8. Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011. 123:522–527.

9. Barwick TD, Rockall AG, Barton DP, Sohaib SA. Imaging of endometrial adenocarcinoma. Clin Radiol. 2006. 61:545–555.

10. Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr. 1995. 19:766–772.

11. Trope CG, Alektiar KM, Sabbatini PJ, Zaino RJ. Hoskins WJ, editor. Ovid Technologies Inc. Corpus: epithelial tumors. Principles and practice of gynecologic oncology. 2005. 4th ed. Philadelphia: Lippincott Williams & Wilkins;823–872.

12. Signorelli M, Guerra L, Montanelli L, Crivellaro C, Buda A, Dell'Anna T, et al. Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? Gynecol Oncol. 2011. 123:236–240.

13. Savelli L, Testa AC, Mabrouk M, Zannoni L, Ludovisi M, Seracchioli R, et al. A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer. Gynecol Oncol. 2012. 124:549–552.

14. Sood AK, Buller RE, Burger RA, Dawson JD, Sorosky JI, Berman M. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol. 1997. 90:441–447.

15. Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol. 2000. 182:1328–1334.

16. Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol. 1990. 163:1204–1209.

17. Takami M, Sakamoto H, Ohtani K, Takami T, Satoh K. An evaluation of CA125 levels in 291 normal postmenopausal and 20 endometrial adenocarcinoma-bearing women before and after surgery. Cancer Lett. 1997. 121:69–72.

18. Garg G, Morris RT, Solomon L, Toy EP, Kruger M, Clary K, et al. Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Gynecol Oncol. 2011. 123:208–213.